This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: The Innovations of Robert F. Meyer
Introduction
Robert F. Meyer is an accomplished inventor based in Royersford, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of CETP inhibitors. His work focuses on enhancing the efficacy of these compounds through innovative formulations.
Latest Patents
Robert F. Meyer holds 1 patent for his invention titled "Polymer formulations of CETP inhibitors." This pharmaceutical composition includes a CETP inhibiting compound or a pharmaceutically acceptable salt, a concentration-enhancing polymer, and optionally one or more surfactants. The composition is designed to raise HDL-cholesterol and lower LDL-cholesterol, showcasing its potential impact on cardiovascular health.
Career Highlights
Meyer is associated with Merck Sharp & Dohme Corp., a leading global healthcare company. His role at Merck has allowed him to work on groundbreaking research and development projects that aim to improve patient outcomes through innovative drug formulations.
Collaborations
Throughout his career, Robert has collaborated with talented professionals, including Sarah Geers and Michael Lowinger. These partnerships have fostered a creative environment that encourages the exchange of ideas and expertise in the pharmaceutical field.
Conclusion
Robert F. Meyer exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the area of CETP inhibitors, highlight the importance of research and collaboration in developing effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile